Suppr超能文献

接受胸部男性化手术患者的偶然非典型性:一项观察性系列研究

Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series.

作者信息

Kolbow Madison, Cohen Jade, Prathibha Saranya, Marmor Schelomo, Buckley Marie-Claire, Hui Jane Yuet Ching

机构信息

University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA.

出版信息

Transgend Health. 2025 Jun 5;10(3):297-301. doi: 10.1089/trgh.2023.0011. eCollection 2025 Jun.

Abstract

This retrospective study investigated the incidence of breast atypia and breast cancer (BC) in patients undergoing chest masculinization surgery. Of the 880 patients included, 7 (0.8%) were diagnosed with atypia and none with BC. The median age at surgery for patients without and with atypia was 25.0 and 36.0 years, respectively. Preoperative testosterone therapy utilization was similar among patients with atypia (71%) and patients without (79%). No patients with atypia were diagnosed with subsequent BC during a median follow-up of 37 months. Appropriate BC screening and risk management for patients undergoing chest masculinization surgery should be further elucidated.

摘要

这项回顾性研究调查了接受胸部男性化手术患者的乳腺异型增生和乳腺癌(BC)发病率。在纳入的880例患者中,7例(0.8%)被诊断为异型增生,无患者被诊断为乳腺癌。无异型增生和有异型增生患者的手术中位年龄分别为25.0岁和36.0岁。异型增生患者(71%)和无异型增生患者(79%)术前睾酮治疗的使用率相似。在中位随访37个月期间,没有异型增生患者被诊断为后续乳腺癌。对于接受胸部男性化手术的患者,应进一步阐明适当的乳腺癌筛查和风险管理。

相似文献

1
Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series.
Transgend Health. 2025 Jun 5;10(3):297-301. doi: 10.1089/trgh.2023.0011. eCollection 2025 Jun.
6
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
8
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
9
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.
JAMA Surg. 2024 Feb 1;159(2):193-201. doi: 10.1001/jamasurg.2023.6382.
10
What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
Clin Orthop Relat Res. 2024 Dec 1;482(12):2149-2160. doi: 10.1097/CORR.0000000000003186. Epub 2024 Jul 9.

本文引用的文献

1
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
2
3
Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
Ann Intern Med. 2022 Apr;175(4):471-478. doi: 10.7326/M21-3577. Epub 2022 Mar 1.
4
ACR Appropriateness Criteria® Transgender Breast Cancer Screening.
J Am Coll Radiol. 2021 Nov;18(11S):S502-S515. doi: 10.1016/j.jacr.2021.09.005.
5
Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging.
J Am Coll Radiol. 2021 Sep;18(9):1280-1288. doi: 10.1016/j.jacr.2021.04.021. Epub 2021 Jun 19.
6
Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.
Obstet Gynecol. 2021 Mar 1;137(3):e75-e88. doi: 10.1097/AOG.0000000000004294.
7
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review.
Clin Breast Cancer. 2021 Jun;21(3):e154-e157. doi: 10.1016/j.clbc.2020.10.005. Epub 2020 Nov 10.
8
Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening.
Breast. 2020 Oct;53:92-100. doi: 10.1016/j.breast.2020.06.008. Epub 2020 Jul 2.
10
Testosterone therapy and risk of breast cancer development: a systematic review.
Curr Opin Urol. 2020 May;30(3):340-348. doi: 10.1097/MOU.0000000000000763.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验